Inventor
THURKAUF ANDREW
US76 patents
⚠️ This page may combine multiple inventors who share the name “THURKAUF ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
42 patentsUS5633376AMay 27, 1997
Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands
NEUROGEN CORP57 citations96
US5212310AMay 18, 1993
Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP89 citations96
US6569861B2May 27, 2003
Melanin concentrating hormone receptor ligands
NEUROGEN CORP33 citations93
US6172229B1Jan 9, 2001
1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands
NEUROGEN CORP26 citations93
US5859246AJan 12, 1999
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
NEUROGEN CORP27 citations93
US5817813AOct 6, 1998
Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP24 citations93
US5681956AOct 28, 1997
4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
NEUROGEN CORP29 citations93
US5625063AApr 29, 1997
Certain aryl fused imidazaopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP30 citations93
US5594141AJan 14, 1997
Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
NEUROGEN CORP28 citations93
US5326868AJul 5, 1994
Certain aryl fused pyrrolopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP25 citations93
US5159083AOct 27, 1992
Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
NEUROGEN CORP33 citations93
US6723743B1Apr 20, 2004
High affinity small molecule C5a receptor modulators
NEUROGEN CORP32 citations92
US6284761B1Sep 4, 2001
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
NEUROGEN CORP26 citations92
US6069251AMay 30, 2000
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4- substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
NEUROGEN CORP25 citations92
US5712392AJan 27, 1998
Certain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
NEUROGEN CORP21 citations92
US5633377AMay 27, 1997
4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands
NEUROGEN CORP18 citations92
US5216159AJun 1, 1993
Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP28 citations92
US6316470B1Nov 13, 2001
Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
NEUROGEN CORP17 citations89
US6084098AJul 4, 2000
Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
NEUROGEN CORP27 citations89
US6013650AJan 11, 2000
Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP23 citations88
US7169775B2Jan 30, 2007
Amino methyl imidazoles as C5a receptor modulators
NEUROGEN CORP12 citations84
US6515133B1Feb 4, 2003
Pharmaceutical compositions containing certain diarylimidazole derivatives
NEUROGEN CORP16 citations84
US5656762AAug 12, 1997
4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands
NEUROGEN CORP9 citations82
US5646280AJul 8, 1997
Substituted 4-(alkyl, dialkyl) or cycloaklyl)aminomethyl 2-phenylimidazoes: dopamine receptor subtype specific ligands
NEUROGEN CORP17 citations82
US7186734B2Mar 6, 2007
Aryl imidazoles and related compounds as C5a receptor modulators
NEUROGEN CORP6 citations74
US6797824B2Sep 28, 2004
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
NEUROGEN CORP4 citations74
US6753336B2Jun 22, 2004
Melanin concentrating hormone receptor ligands
NEUROGEN CORP7 citations74
US6544996B2Apr 8, 2003
1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
NEUROGEN CORP8 citations74
US6426347B2Jul 30, 2002
1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
NEUROGEN CORP4 citations74
US6358955B1Mar 19, 2002
Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazole
NEUROGEN CORP5 citations74
US6121260ASep 19, 2000
Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
NEUROGEN CORP13 citations74
US5773616AJun 30, 1998
Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
NEUROGEN CORP5 citations74
US5646279AJul 8, 1997
Substituted 4-piperazinylmethyl 2-phenylimidazoles; dopamine receptor subtype specific ligands
NEUROGEN CORP5 citations74
US5646281AJul 8, 1997
Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
NEUROGEN CORP6 citations74
US5463054AOct 31, 1995
Certain aryl fused pyrrolopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP14 citations74
US6884815B1Apr 26, 2005
High affinity small molecule C5a receptor modulators
NEUROGEN CORP9 citations73
US6482844B1Nov 19, 2002
1-benzylimidazole derivatives
NEUROGEN CORP13 citations73
US5585490ADec 17, 1996
Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands
NEUROGEN CORP15 citations73
US6294530B1Sep 25, 2001
1-azatricyclic-4-benzylpiperazines
NEUROGEN CORP7 citations71
US6444819B1Sep 3, 2002
Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
NEUROGEN CORP7 citations68
US6656943B2Dec 2, 2003
1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
NEUROGEN CORP3 citations63
US6355644B1Mar 12, 2002
Benzylpiperazinyl-indolinylethanones
NEUROGEN CORP6 citations63
ACHILLION PHARMACEUTICALS INC
6 patentsUS7767706B2Aug 3, 2010
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC23 citations92
US7476686B2Jan 13, 2009
Substituted aryl thioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC23 citations92
US7094807B2Aug 22, 2006
Substituted aryl thioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC20 citations92
US7439374B2Oct 21, 2008
Azabenzofuran substituted thioureas; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC11 citations84
US7718671B2May 18, 2010
Substituted arylthiourea derivatives useful as inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC10 citations83
US7365068B2Apr 29, 2008
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC11 citations83
NOVARTIS INT PHARM LTD
1 patentSEARLE & CO
1 patentShowing the top 50 of 76 patents by PatentIndex Score.